Founder and President

(she/her/hers)

Teresa Norris is a dynamic leader in sexual health education, recognized for her extensive expertise in Human Papillomavirus (HPV). As the Founder and President of HPV Global Action, an international Canadian charity, she has dedicated over two decades to advancing public health through innovative, evidence-based communication strategies.

Teresa’s dedication to her field is deeply personal, driven by the loss of a close friend to cervical cancer at a young age. This experience fuels her commitment to promoting healthy relationships and prevention. An accomplished public speaker and educator, Teresa is known for her ability to engage audiences of all ages, effectively delivering complex information in an accessible and impactful way.

Her contributions extend beyond education; Teresa is actively involved in research, project management. She oversees significant international initiatives, including the Integration project (Introducing Novel Tools to Enhance Gynecological Research and Treatment), which aims to reduce the vulnerability of women in Eswatini to diseases and prevent long-term health consequences of cervical cancer and Female Genital Schistosomiasis (FGS). As Lead Principal Investigator, she collaborates with the U.S. National Cancer Institute (NCI) and other national and international organizations and governments.

Under Teresa’s guidance, HPV Global Action has spearheaded projects that have driven policy changes and expanded access to HPV vaccination and cervical cancer screening across Canada. Additionally, she serves as a lecturer at the University of Quebec in Montreal, where she teaches sexual health education and communication techniques, further extending her impact on future generations of health professionals. Her contributions to public health continue to shape the landscape of sexual and reproductive health in Canada and beyond.

Publications

Design of the HPV-Automated Visual Evaluation (PAVE) Study: Validating a Novel Cervical Screening Strategy
Silvia de Sanjosé Rebecca B PerkinsNicole Campos, Federica InturrisiDidem Egemen, Brian Befano, Ana Cecilia Rodriguez, Jose Jerónimo, Li C Cheung,Kanan Desai, Paul Han, Akiva P Novetsky, Abigail Ukwuani, Jenna Marcus, Syed Rakin Ahmed, Nicolas Wentzensen, Jayashree Kalpathy-Cramer, Mark Schiffman On behalf of the PAVE Study Group

Ensuring a Successful Transition From Cytology to Human Papillomavirus
Gabrielle Griffin-Mathieu; Ben Haward; Ovidiu Tatar; Patricia Zhu; Samara Perez; Gilla K Shapiro; Emily McBride; Erika L Thompson; Laurie W Smith; Aisha K Lofters; Ellen M Daley; Juliet R Guichon; Jo Waller; Marc Steben; Kathleen M Decker; Marie-Helene Mayrand; Julia M L Brotherton; Gina S Ogilvie; Gregory D Zimet; Teresa Norris; Zeev Rosberger;

WHO calls ISSVD to action on elimination of female genital Shistosomiasis
Marc Steben, MD; Eyrun Floerecke Kjetland; Teresa Norris

COVID-19 Won’t Be the Last (Or Worst) Pandemic: It’s Time to Build Resilience Into Our Cervical Cancer Elimination Goals
Marc Steben, MD; Teresa Norris; Zeev Rosberger, PhD

Canada’s Role in Accelerating Global Elimination of Cervical Cancer
Marc Steben, MD; George Wurtak, MED; Silvia de Sanjosé, MD; Marina Salvadori, MD; Francois Coutlée, MD; Alberto Severini, MD; Salah Mahmud, MD; Eduardo Franco, doctorat en santé publique; Ann N. Burchell, PhD; Hélène M. Gagné, MD; James Bentley, MBBS; Laurie Elit, MD; Magali Lecavalier-Barsoum, MD; Deborah Dudgeon, MD; Nitika Pant Pai, MD; Angela Karellis, MSc; Catherine Popadiuk, MD; Laurie W. Smith, IA certifiée.Inf.; Teresa Norris; Amelie McFadyen, MA; Jennifer Blake, MD; Roger Simard, B. Pharm;

Design of the HPV-automated visual evaluation (PAVE) study: Validating a novel cervical screening strategy
Silvia de Sanjosé,1,2 Rebecca B Perkins,3 Nicole Campos,4 Federica Inturrisi,1 Didem Egemen,1 Brian Befano,5,6 Ana Cecilia Rodriguez,1 Jose Jerónimo,1 Li C Cheung,1 Kanan Desai,1 Paul Han,7 Akiva P Novetsky,8 Abigail Ukwuani,1 Jenna Marcus,9 Syed Rakin Ahmed,10,11,12,13 Nicolas Wentzensen,1 Jayashree Kalpathy-Cramer,10,14 and Mark Schiffman1, On behalf of the PAVE Study Group

A mixed two-dose vaccination schedule: Not enough evidence to support a policy change in Quebec
Zeev Rosberger; Marc Steben; Teresa Norris; Amelie McFadyen ; Gilla K. Shapiro